Riskpilot← Back to searchSign inGet full accessFKD Therapies Oy
OYActiveY-tunnus 2389119-2Sädekuja 5Research and experimental development on natural sciences and engineering · NACE 7210Est. 2011— employees
Revenue 2024
EUR 2,8M
-24% vs 2023
EBITDA margin
0.0%
-100% vs 2023
Equity ratio
0.0%
Financial strength
Net profit 2024
EUR -3K
-101% vs 2023
| Revenue | EUR 2,8M | -24% |
| EBITDA | EUR 1K | -100% |
| Net profit | EUR -3K | -101% |
| Total assets | EUR 1,3M | +76% |
| Equity | EUR 286 | -100% |
| Employees | — | — |
Legal name
FKD Therapies Oy
Y-tunnus number
2389119-2
Legal form
Osakeyhtiö
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
3. helmikuuta 2011
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on biotekniikan ja lääketieteen tutkimus ja tuotekehittely, alan hoito-, koulutus-, konsultaatio- ja tutkimuspalvelut, sekä näihin liittyvien tuotteiden valmistus, maahantuonti, myynti ja vuokraus. Yhtiö voi toimintaansa varten omistaa ja hallita tarpeellisia kiinteistöjä, osakkeita ja muita arvopapereita. Yhtiö voi rahoittaa lähipiiriin kuuluvaa ja sellainen voi rahoittaa yhtiötä.
Address
Sädekuja 5
Phone
+3580505390555
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 920 | 3 633 | 367 | 3 617 | 2 763 |
| Staff expenses | −140 | — | — | −0 | −0 |
| EBITDA | 40 | 3 009 | 2 | 501 | 1 |
| Depreciation & amort. | — | — | — | −0 | −0 |
| EBIT | 40 | 3 009 | 2 | 501 | 1 |
| Net financials | −8 | −15 | −2 | −83 | −1 |
| Profit before tax | 32 | 2 995 | −0 | 417 | 1 |
| Tax | 7 | 602 | −0 | 85 | 4 |
| Net profit | 25 | 2 392 | −0 | 333 | −3 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 116 | 3 145 | 563 | 748 | 1 313 |
| Equity | 1 113 | 2 506 | 506 | 438 | 0 |
| Long-term debt | — | — | — | 0 | 0 |
| Short-term debt | 1 003 | 639 | 57 | 47 | 3 |
| Total debt | 1 003 | 639 | 57 | 309 | 1 313 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20202024
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
20202024
Return on equity
-1078.0%
This company
18.4%
Market median
-5959% vs market
20202024
Net profit margin
-0.1%
This company
8.1%
Market median
-101% vs market
20202024
Asset turnover
2.11×
This company
1.12×
Market median
+88% vs market
20202024
Debt / equity
4588.36×
This company
0.62×
Market median
-739958% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JP Confidential Clerk | Confidential Clerk | 2022 |
| Former (6) | ||
MM | Audit | 2018 – 2020 |
AJ Audit | Audit | 2020 – 2023 |
TA Chief Executive Officer | Chief Executive Officer | 2016 – 2020 |
SP Deputy Member | Deputy Member | 2018 – 2021 |
NR Deputy Member | Deputy Member | 2018 – 2021 |
AM Confidential Clerk | Confidential Clerk | 2021 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2024 | |
| Chairperson | 2024 | |
| Board of Directors | 2022 | |
| Former (5) | ||
| Board of Directors | 2021 – 2024 | |
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2018 – 2021 | |
| Board of Directors | 2021 – 2022 | |
| Chairperson | 2021 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FKD Therapies Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Miia Maria Anneli Marjamäki | Audit | 0 companies |
| Jouko Petteri Prami | Confidential Clerk | 0 companies |
| Antti Juhani Rönkkö | Audit | 0 companies |
| Timo Antero Ristola | Chief Executive Officer | 0 companies |
| Seppo Pasi Antero Ylä-Herttuala | Deputy Member | 0 companies |
| Nigel Richard Parker | Deputy Member | 0 companies |
| Arttu Matias Ruuska | Confidential Clerk | 0 companies |
| Jean-Frédéric Paulsen | Board of Directors | 0 companies |
| Nathalie Ruffin | Board of Directors | 0 companies |
| Jose Javier Enriquez | Chairperson | 0 companies |
| Erik Henricus Maria Schropp | Board of Directors | 0 companies |
| Robert Shaw | Board of Directors | 0 companies |
| Niko Miika Petteri Natunen | Board of Directors | 0 companies |
| Jesse Alan Fecker | Board of Directors | 0 companies |
| Margaret Jo Wynne | Chairperson | 0 companies |